Monday, September 30, 2019

15 hours ago - That policy relied on "enforcement discretion" to allow bulk compounding of vasopressin, the active ingredient in Vasostrict(R) , which is manufactured by Endo's ..
8 hours ago - The company had initially sued the FDA in October 2017, challenging its interim policy authorizing the bulk compounding of drugs, including Endo's antidiuretic 

No comments: